Astellas Pharma Competitors and Similar CompaniesClear all

Astellas Pharma's competitors and similar companies include Bayer, Nipro Corporation, Immunomedics, Shionogi, Urovant Sciences and Viatris.
Astellas Pharma
Astellas Pharma
Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.
Bayer
Bayer
Bayer is a life sciences company specializing in healthcare and nutrition.
Nipro Corporation
Nipro Corporation
Nipro Corporation (ニプロ株式会社) is a company that develops medical devices, pharmaceuticals, and pharma packaging.
Immunomedics
Immunomedics
Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.
Shionogi
Shionogi
Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases.
Urovant Sciences
Urovant Sciences
Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions.
Viatris
Viatris
Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products.
Founding Date
Founding Date
1923
Founding Date
1863
Founding Date
1954
Founding Date
1982
Founding Date
1878
Founding Date
2016
Founding Date
2020
Type
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Tokyo, JP HQ
Macquarie Park, AU
Wien, AT
Vilvoorde, BE
São Paulo, BR
Markham, CA
Beijing, CN
see more
Locations
Leverkusen, DE HQ
Tirana, AL
Dely Ibrahim, DZ
Luanda, AO
Munro, AR
Pymble, AU
Wien, AT
see more
Locations
Osaka, JP HQ
Bunkyo City, JP
Kusatsu, JP
Kusatsu, JP
Ohdate, JP
Locations
Morris Plains, US HQ
Locations
Osaka, JP HQ
Beijing, CN
Hong Kong, HK
Amagasaki, JP
Amagasaki, JP
Kanegasaki, JP
Misato, JP
see more
Locations
Irvine, US HQ
Basel, CH
Locations
Canonsburg, US HQ
Carole Park, AU
Millers Point, AU
Campos Dos Goytacazes, BR
São Paulo, BR
Sofia, BG
Toronto, CA
see more
Employees
Employees
14,484
Employees
99,7231% decrease
Employees
38,770
Employees
1061% decrease
Employees
5,680
Employees
3950% increase
Employees
38,0003% increase
Valuation ($)
Valuation ($)
17.9 b
Valuation ($)
31.3 b
Valuation ($)
1.2 b
Valuation ($)
N/A
Valuation ($)
12.5 b
Valuation ($)
531.8 m
Valuation ($)
12.4 b
Twitter followers
Twitter followers
50.4 k
Twitter followers
184.4 k
Twitter followers
N/A
Twitter followers
568
Twitter followers
N/A
Twitter followers
221
Twitter followers
8.3 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
25
Number of tweets (last 30 days)
30
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
4
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
5.8
Average likes per tweet (last 30 days)
10
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
3
Average likes per tweet (last 30 days)
9
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
96%
Percentage of tweets with engagement (last 30 days)
73.33%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%

Financial

Revenue (est.)
Revenue (est.)
¥1.5t (FY, 2023)
Revenue (est.)
€47.6b (FY, 2023)
Revenue (est.)
¥442.5b (FY, 2020)
Revenue (est.)
$295k (FY, 2019)
Revenue (est.)
¥435.1b (FY, 2024)
Revenue (est.)
N/A
Revenue (est.)
$15.4b (FY, 2023)
Cost of goods
Cost of goods
¥182.6b (FY, 2023)
Cost of goods
€7b (FY, 2023)
Cost of goods
¥308.3b (FY, 2020)
Cost of goods
N/A
Cost of goods
¥39.3b (FY, 2024)
Cost of goods
N/A
Cost of goods
$9b (FY, 2023)
Gross profit
Gross profit
¥1.3t (FY, 2023)
Gross profit
€42.1b (FY, 2023)
Gross profit
¥134.2b (FY, 2020)
Gross profit
$295k (FY, 2019)
Gross profit
¥402b (FY, 2024)
Gross profit
N/A
Gross profit
$6.4b (FY, 2023)
Net income
Net income
¥98.7b (FY, 2023)
Net income
(€2.9b) (FY, 2023)
Net income
(¥11.6b) (FY, 2020)
Net income
($357.3m) (FY, 2019)
Net income
¥160.6b (FY, 2024)
Net income
($146.7m) (FY, 2020)
Net income
$54.7m (FY, 2023)

Operating

Countries
Countries
N/A
Countries
83 (FY, 2021)
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Countries
165 (Q1, 2023)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 3.5b
Total funding raised
N/A
Total funding raised
$ 30m
Total funding raised
$ 4.7m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Bayer
HQ
Leverkusen, DE
Employees
99,723↓ 1% decrease

Bayer is a life sciences company specializing in healthcare and nutrition.

View company
Nipro Corporation
HQ
Osaka, JP
Employees
38,770

Nipro Corporation (ニプロ株式会社) is a company that develops medical devices, pharmaceuticals, and pharma packaging.

View company
Immunomedics
HQ
Morris Plains, US

Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.

View company
Shionogi
HQ
Osaka, JP
Employees
5,680

Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases.

View company